HAVCR1 and systemic lupus erythematosus: In murine lupus models, systemic administration of miR-10a-3p reversed these changes and also improved renal function, 24-h urine protein, markers of renal injury such as kidney injury molecule-1 (KIM-1) and decreased anti-dsDNA levels.